Services and laboratories » Services and Laboratories » Ambulatorio per la Diagnosi e la terapia del Morbo di Parkinson » Pubblications

Sforza C, Rango M, Galante D, Bresolin N, Ferrario VF.
Spontaneous blinking in healthy persons: an optoelectronic study of eyelid motion.
Ophthalmic Physiol Opt. 2008 Jul;28(4):345-53.
PMID: 18565090 [PubMed - in process]

Rango M, Arighi A, Biondetti P, Barberis B, Bonifati C, Blandini F, Pacchetti C, Martignoni E, Bresolin N, Nappi G.
Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes.
Funct Neurol. 2007 Apr-Jun;22(2):75-9. Review.
PMID: 17637209 [PubMed - indexed for MEDLINE]

Ghione I, Di Fonzo A, Saladino F, Del Bo R, Bresolin N, Comi GP, Rango M.
Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease.
Neurotoxicology. 2007 May;28(3):698-701. Epub 2007 Jan 20.
PMID: 17335904 [PubMed - indexed for MEDLINE]

Rango M, Canesi M, Ghione I, Farabola M, Righini A, Bresolin N, Antonini A, Pezzoli G.
Parkinson's disease, chronic hydrocarbon exposure and striatal neuronal damage: a 1-H MRS study.
Neurotoxicology. 2006 Mar;27(2):164-8. Epub 2005 Oct 21.
PMID: 16246421 [PubMed - indexed for MEDLINE]

Rango M, Bonifati C, Bresolin N.
Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study.
J Cereb Blood Flow Metab. 2006 Feb;26(2):283-90.
PMID: 16094320 [PubMed - indexed for MEDLINE]

Sciacco M, Prelle A, D'Adda E, Lamperti C, Bordoni A, Rango M, Crimi M, Comi GP, Bresolin N, Moggio M.
Familial mtDNA T8993C transition causing both the NARP and the MILS phenotype in the same generation. A morphological, genetic and spectroscopic study.
J Neurol. 2003 Dec;250(12):1498-500. No abstract available.
PMID: 14673588 [PubMed - indexed for MEDLINE]

Rango M, Bozzali M, Prelle A, Scarlato G, Bresolin N.
Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: a phosphorus magnetic resonance spectroscopy study.
J Cereb Blood Flow Metab. 2001 Jan;21(1):85-91.
PMID: 11149672 [PubMed - indexed for MEDLINE]

Rango M, Castelli A, Scarlato G.
Energetics of 3.5 s neural activation in humans: a 31P MR spectroscopy study.
Magn Reson Med. 1997 Dec;38(6):878-83.
PMID: 9402187 [PubMed - indexed for MEDLINE]

Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L.
Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study.
Magn Reson Med. 1995 May;33(5):595-600.
PMID: 7596262 [PubMed - indexed for MEDLINE]

Rango M, Lenkinski RE, Alves WM, Cruz J, Gennarelli TA.
Brain pH in acute head injury.
Minerva Anestesiol. 1993 Dec;59(12):835-6. No abstract available.
PMID: 8177434 [PubMed - indexed for MEDLINE]

Rango M, Lenkinski RE, Alves WM, Gennarelli TA.
Brain pH in head injury: an image-guided 31P magnetic resonance spectroscopy study.
Ann Neurol. 1990 Nov;28(5):661-7.
PMID: 2260853 [PubMed - indexed for MEDLINE]

Rango M, Candelise L, Perani D, Messa C, Scarlato G, Canal N, Franceschi M, Fazio F.
Cortical pathophysiology and clinical neurologic abnormalities in acute cerebral ischemia. A serial study with single photon emission computed tomography.
Arch Neurol. 1989 Dec;46(12):1318-22.
PMID: 2590016 [PubMed - indexed for MEDLINE]

Rango M, Farabola M, Canesi M, et al.
Parkinson's disease, exposure to toxic substances and basal nuclei
RIV NEURORADIOL 14: 47-48 Suppl. 3 DEC 2001

Rango M, Bozzali M, Prelle A, et al.
Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: A phosphorus magnetic resonance spectroscopy study
J CEREBR BLOOD F MET 21 (1): 85-91 JAN 2001

Rango M, Righini A, Farabola M, et al.
Parkinson's disease, toxic exposure, and basal ganglia: A proton magnetic resonance spectroscopy study
NEUROLOGY 54 (7): A445-A445 Suppl. 3 APR 11 2000

Rango M, Bozzali M, Castelli A, et al.
Brain lactate and high energy phosphates in patients with mitochondrial disease without central nervous system involvement: A magnetic resonance spectroscopy-brain activation study
NEUROLOGY 52 (6): A158-A158 Suppl. 2 APR 1999

Bozzali M, Rango M, Prelle A, et al.
Brain activation in patients with mitochondrial disease without central nervous system involvement: A 31 P magnetic resonance spectroscopy study
NEUROLOGY 50 (4): P01039 Suppl. 4 APR 1998

Rango M, Castelli A, Scarlato G
Energetics of 3.5 s neural activation in humans: a P-31 MR spectroscopy study
MAGNET RESON MED 38 (6): 878-883 DEC 1997

RANGO M, SPAGNOLI D, TOMEI G, et al.
CENTRAL-NERVOUS-SYSTEM TRANSSYNAPTIC EFFECTS OF ACUTE AXONAL INJURY - A H-1 MAGNETIC-RESONANCE SPECTROSCOPY STUDY
MAGNET RESON MED 33 (5): 595-600 MAY 1995

RANGO M, LENKINSKI RE, ALVES WM, et al.
BRAIN PH IN HEAD-INJURY - AN IMAGE-GUIDED P-31 MAGNETIC-RESONANCE SPECTROSCOPY STUDY
ANN NEUROL 28 (5): 661-667 NOV 1990

GREENBERG JH, KUSHNER M, RANGO M, et al.
VALIDATION STUDIES OF IODINE-123-IODOAMPHETAMINE AS A CEREBRAL BLOOD-FLOW TRACER USING EMISSION TOMOGRAPHY
J NUCL MED 31 (8): 1364-1369 AUG 1990

KUSHNER M, NENCINI P, REIVICH M, RANGO M et al.
RELATION OF HYPERGLYCEMIA EARLY IN ISCHEMIC BRAIN INFARCTION TO CEREBRAL ANATOMY, METABOLISM, AND CLINICAL OUTCOME
ANN NEUROL 28 (2): 129-135 AUG 1990